2min chapter

Docs Who Lift cover image

Olympic controversies and GLP-1 for Alzheimer's and Heart Failure

Docs Who Lift

CHAPTER

Exploring GLP-1 Impacts on Alzheimer’s and Diabetes Management

This chapter discusses the impact of drugs like samaglitide and terzepatide on type 2 diabetes, obesity, and their possible connections to Alzheimer's Disease. It also highlights Eli Lilly's role in the release of these medications and their sponsorship of Olympic events, underlining the importance of these developments in public health.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode